RACGP Crest

Guidelines for preventive activities in general practice 7th edition

Skip to content
Large font
Medium font
Small font

Full index

Introduction and user guide

Preventive activities before pregnancy

Genetic counselling and testing

Preventive activities in children and young people

Preventive activities in middle age

Preventive activities in older age

Communicable diseases

Prevention of chronic disease

Prevention of vascular and metabolic disease

Early detection of cancers

Psychosocial

Oral hygiene

Glaucoma

Urinary incontinence

Osteoporosis

Screening tests of unproven benefit

References

Appendices

Glossary

Acronyms

Acknowledgements

Disclaimer

Download the full PDF version of Guidelines for preventive activities in general practice 7th edition (396Kb)

 

Glaucoma

Glaucoma age range table
Age 0 - 9 10 - 14 15 - 19 20 - 24 25 - 29 30 - 34 35 - 39 40 - 44 45 - 49 50 - 54 55 - 59 60 - 64 65 - 69 70 - 79 >80
                               

There is insufficient evidence to recommend routine screening for glaucoma using tonometry or visual fields test (C).455 However, GPs have an essential role in identifying patients at higher risk for glaucoma, and referring them for testing.

Glaucoma risk
Who is at higher risk of glaucoma? What should be done? How often? Level of evidence and references

Increased risk

Patients with:




Refer for ophthalmoscopy, tonometry and visual field assessment*



Every 12 months



III C 456
Glaucoma intervention
Intervention Technique References
Tonometry Tonometry is not recommended. Schiotz tonometry has poor sensitivity and specificity for early detection of glaucoma. Tonometry is an inadequate screening tool as it grossly overestimates glaucoma prevalence (C)
Perimetry (visual fields) Not advisable in general practice as only automated perimetry is sensitive for detecting glaucoma (C) 458,548
Fundus (ophthalmoscopy) There is some evidence that new generation (panoptic) ophthalmoscopes can better detect glaucomatous discs as well as macular degeneration and diabetic retinopathy (B) 459

Back to top